- 2025-04-12 17:36HBV Seq2 aa:28-39 168417-72-9
- 2025-04-12 17:36hFSH-β-(33-53) (TFA)
- 2025-04-12 17:36Quizartinib HCl (AC-220; AC-010220) 1132827-21-4
- 2025-04-12 17:36Bedoradrine 194785-19-8
- 2025-04-12 17:36DBM-MMAF 1810001-93-4
- 2025-04-12 17:36Antioxidant agent-9 71835-79-5
- 2025-04-12 17:36ABBV-154
- 2025-04-12 17:36Lucitanib dihydrochloride 2108875-91-6
- 2025-04-12 17:36BMAP-28 184870-31-3
- 2025-04-12 17:36HCV Peptide (131-140) 160926-86-3
- 2025-04-12 17:36Duocarmycin Analog 372954-15-9
- 2025-04-12 17:36Cap-dependent endonuclease-IN-2 2303917-78-2
- 2025-04-12 17:36EGFR T790M/L858R-IN-4 3032760-34-9
- 2025-04-12 17:36(S,E)-TCO2-PEG4-NHS ester
- 2025-04-12 17:361-Tetradecanol (Tetradecyl Alcohol) 112-72-1
- 2025-04-12 17:366-O-Methylcatalpol 1617-84-1
- 2025-04-12 17:36AR antagonist 5 2902679-53-0
- 2025-04-12 17:364-Phenylbutyric acid-d2 (4-PBA-d2; Benzenebutyric acid-d2) 461391-24-2
- 2025-04-12 17:36HBV Seq2 aa:208-216 160214-63-1
- 2025-04-12 17:36Novolimus 151519-50-5
